Directory

>

Katie Peng

avatar

Katie Peng

Board Member | Denali Therapeutics

South San Francisco, California, United States

View contact details (it's free)

Katie Peng

Summary

Katie Peng is an accomplished Chief Commercial Officer and Independent Board Director with extensive experience in the biopharmaceutical industry. With a career spanning over two decades, she has successfully managed businesses for leading companies like Genentech and Roche across diverse regions including the U.S. and Asia-Pacific. Currently, she oversees a significant portion of Genentech's portfolio, focusing on therapeutic areas such as Neurology and Immunology. Katie is passionate about fostering inclusive work environments that empower teams to deliver innovative solutions for patients. She has held various leadership roles, demonstrating a strong track record in commercialization and product launch. Her educational background includes a BA in Biology from UC Berkeley and an MBA from the Kelley School of Business. Katie's strategic insights and commitment to excellence have positioned her as a key player in the biotechnology sector.

General

Generalist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Industry-specific interests

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Katie Peng

Work Experience

company logo

Board Member at

Scholar Rock

February 2024 - Present

company logo

Board Member at

Adicet Bio, Inc

July 2023 - Present

company logo

Chief Commercial Officer at

Denali Therapeutics

September 2021 - Present

company logo

Sr. Vice President, OMNI Business Unit Head at

Genentech Foundation

November 2019 - September 2021

company logo

Sr. Vice President, Sales & Marketing at

Genentech Foundation

April 2017 - October 2019

company logo

General Manager, Taiwan at

ROCHE LEON HOLDINGS

March 2015 - January 2017

company logo

General Manager, Singapore at

ROCHE LEON HOLDINGS

January 2012 - January 2014

company logo

Marketing Director, Tarceva at

Genentech Foundation

January 2010 - January 2012

company logo

Sales and Marketing, Oncology at

Genentech Foundation

January 2004 - January 2010

company logo

Sales, Marketing and Business Analytics at

Amgen, Inc.

January 2000 - January 2004

Logos provided by Logo.dev

Frequently Asked Questions about Katie Peng

What is Katie Peng email address?

Katie Peng's primary email address is **********@gene.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Katie Peng work for?

Katie Peng is a Board Member at Denali Therapeutics, a company specializing in Commercial physical research.

Where Katie Peng graduated from?

Katie Peng holds a degree in Biology from University of California, Berkeley.

How can I directly contact Katie Peng?

To contact Katie Peng directly, you can use the email address **********@gene.com. Complete contact information is available upon registration with Muraena.

Who is Katie Peng?

Katie Peng is an accomplished Chief Commercial Officer and Independent Board Director with extensive experience in the biopharmaceutical industry. With a career spanning over two decades, she has successfully managed businesses for leading companies like Genentech and Roche across diverse regions including the U.S. and Asia-Pacific. Currently, she oversees a significant portion of Genentech's portfolio, focusing on therapeutic areas such as Neurology and Immunology. Katie is passionate about fostering inclusive work environments that empower teams to deliver innovative solutions for patients. She has held various leadership roles, demonstrating a strong track record in commercialization and product launch. Her educational background includes a BA in Biology from UC Berkeley and an MBA from the Kelley School of Business. Katie's strategic insights and commitment to excellence have positioned her as a key player in the biotechnology sector.

Katie`s contact details

mail

**********@gene.com

*****@denalitherapeutics.com

Colleagues

avatar
Sarah Rhodes Martin

VP, US ETV Franchise and Global Product Strategy

avatar
Peter Chin

Sr. Vice President & Head of Late-Stage Clinical Development and Medical Affairs

avatar
Alexander Schuth

Director Board Of Directors

avatar
Eric Strait

Executive Director, Legal Department

avatar
Anthony Delucchi

Vice President, Technical Operations

avatar
Terry Hudson

Executive Director

avatar
Laura Hansen

Vice President of Investor Relations

avatar
Mitesh Shridhar

Executive Director, Corporate Development

avatar
Leah Frautschy

Vice President, Clinical Manufacturing

View Contact details (it's free)
Request Profile Removal